BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 18528864)

  • 21. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice.
    Ju YH; Fultz J; Allred KF; Doerge DR; Helferich WG
    Carcinogenesis; 2006 Apr; 27(4):856-63. PubMed ID: 16399773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trianthema portulacastrum Linn. exerts chemoprevention of 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats.
    Bishayee A; Mandal A
    Mutat Res; 2014 Oct; 768():107-18. PubMed ID: 24451939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary fat without body weight gain increases in vivo MCF-7 human breast cancer cell growth and decreases natural killer cell cytotoxicity.
    Lamas B; Nachat-Kappes R; Goncalves-Mendes N; Mishellany F; Rossary A; Vasson MP; Farges MC
    Mol Carcinog; 2015 Jan; 54(1):58-71. PubMed ID: 24038423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of estrone on the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in the rat: a model of postmenopausal breast cancer.
    Li S; Martel C; Dauvois S; Bélanger A; Labrie F
    Endocrinology; 1994 Mar; 134(3):1352-7. PubMed ID: 8119175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
    Lindahl G; Saarinen N; Abrahamsson A; Dabrosin C
    Cancer Res; 2011 Jan; 71(1):51-60. PubMed ID: 21097717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells.
    Carreau C; Flouriot G; Bennetau-Pelissero C; Potier M
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):176-85. PubMed ID: 18457947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lignans are accessible to human breast cancer xenografts in athymic mice.
    Saarinen NM; Power KA; Chen J; Thompson LU
    Nutr Cancer; 2008; 60(2):245-50. PubMed ID: 18444157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumorigenic effect of a mammalian lignan precursor from flaxseed.
    Thompson LU; Seidl MM; Rickard SE; Orcheson LJ; Fong HH
    Nutr Cancer; 1996; 26(2):159-65. PubMed ID: 8875553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycine soya diet synergistically enhances the suppressive effect of tamoxifen and inhibits tamoxifen-promoted hepatocarcinogenesis in 7,12-dimethylbenz[α]anthracene-induced rat mammary tumor model.
    Mishra R; Bhadauria S; Murthy PK; Murthy PS
    Food Chem Toxicol; 2011 Feb; 49(2):434-40. PubMed ID: 21092749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo.
    Hsieh CY; Santell RC; Haslam SZ; Helferich WG
    Cancer Res; 1998 Sep; 58(17):3833-8. PubMed ID: 9731492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignan) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells.
    Cosentino M; Marino F; Ferrari M; Rasini E; Bombelli R; Luini A; Legnaro M; Delle Canne MG; Luzzani M; Crema F; Paracchini S; Lecchini S
    Pharmacol Res; 2007 Aug; 56(2):140-7. PubMed ID: 17572100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of stimulatory activity of a phytoestrogen-containing soy extract on the growth of breast cancer tumors in mice.
    Gallo D; Ferlini C; Fabrizi M; Prislei S; Scambia G
    Carcinogenesis; 2006 Jul; 27(7):1404-9. PubMed ID: 16400187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced rat mammary tumorigenesis.
    Chen J; Tan KP; Ward WE; Thompson LU
    Exp Biol Med (Maywood); 2003 Sep; 228(8):951-8. PubMed ID: 12968067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats.
    Lakshmi A; Subramanian S
    Biochimie; 2014 Apr; 99():96-109. PubMed ID: 24299963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta.
    Kang JS; Kim S; Che JH; Nam KT; Kim DJ; Jang DD; Yang KH
    Oncol Rep; 2004 Oct; 12(4):689-93. PubMed ID: 15375486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans.
    Setchell KD; Brown NM; Zimmer-Nechemias L; Wolfe B; Jha P; Heubi JE
    Food Funct; 2014 Mar; 5(3):491-501. PubMed ID: 24429845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.
    González A; Alvarez-García V; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ; Cos S
    Curr Cancer Drug Targets; 2010 May; 10(3):279-86. PubMed ID: 20370689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased antitumor potential of the raloxifene prodrug, raloxifene diphosphate.
    Okamoto Y; Liu X; Suzuki N; Okamoto K; Sekimoto M; Laxmi YR; Shibutani S
    Int J Cancer; 2008 May; 122(9):2142-7. PubMed ID: 18183587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.